1. CoreAge Rx Pore Favor — sponsored first placement
Pore Favor is the compounded prescription cream in this group. Its provider lists salicylic acid, zinc oxide, niacinamide and urea and describes an online intake followed by physician review. Delivery is conditional on a prescription being granted. The starting offer was $42 per month, with free delivery and no membership fees advertised by the provider.
The route gives a prospective patient a place to discuss the concern and current routine. It does not establish eligibility in advance, and we did not verify the outcome of a consultation. The public material reviewed did not establish each ingredient’s strength, the complete base or the exact quantity dispensed. Those are useful questions for the clinician and final purchase terms.
The full Pore Favor review also separates ingredient-level claims from evidence for the finished preparation. As the FDA explains, compounded drugs are not FDA-approved. First placement here reflects sponsorship, not proof that this cream works better than an approved or retail alternative.
2. Differin Adapalene Gel — a labeled retinoid acne option
Differin’s 0.1% adapalene gel is a nonprescription acne medication with an identifiable OTC label. The manufacturer offers multiple pumps, tubes and sizes. We did not establish a single direct price, so this shortlist leaves the price to be checked with the selected retailer rather than importing an unrelated package’s discount.
Its relevant distinction is the medication and its labeled use, not its position beneath our sponsor. It should not be treated as an occasional spot cosmetic or as a general promise to remove visible pores. A clear understanding of the concern and the current directions matters more than a superficial comparison of percentages.
Read the Differin review for the regulatory scope, time-course context and warning sources. A retinoid percentage cannot be directly ranked against a salicylic-acid percentage. Different substances, formulations and treatment roles make that shortcut unreliable.
3. Paula’s Choice 2% BHA Liquid — a clearly identified liquid offer
Paula’s Choice Skin Perfecting 2% BHA Liquid Exfoliant is included as an alternative format. It is not a cream. The selected 4-fluid-ounce bottle showed $37 for a one-time purchase, while $31.45 belonged to a subscription offer with its own terms. The distinction prevents a recurring-order discount from appearing to be the ordinary one-time price.
The product page provides footnotes for claims about pore appearance and other outcomes. Those summaries do not establish a direct comparison with the other three products. We did not appraise the complete studies or test how the liquid felt, and we do not use customer comments as substitutes for those missing observations.
The Paula’s Choice review considers the claim details and explains why a leave-on exfoliant does not automatically replace a moisturizer. A cream-only shopper may decide the liquid format is outside the original brief; keeping the format explicit helps make that decision.
4. La Roche-Posay Effaclar BPO — a current benzoyl-peroxide treatment
The current Effaclar BPO Multi-Target Acne Treatment declares 5.5% benzoyl peroxide. Accessible official-page information showed a selected 20 mL option at $24.99. Direct retrieval was blocked, so the review records that limitation and asks readers to confirm the live offer. The old Effaclar Duo and the brand’s salicylic-acid treatment are separate references.
The brand’s study footnotes distinguish a higher-response subgroup from an average result and distinguish clinical grading from consumer feedback. Those qualifications are important. A prominent short-term result should not become a promise that every user will clear acne in the same period or permanently change pore size.
Our Effaclar BPO review also includes the practical issue of benzoyl-peroxide fabric bleaching and links to medication warnings. Those details can affect daily use even when they are not the most eye-catching part of a product advertisement.
How can the four offers be compared fairly?
Use the question-by-question comparison to look at the access route, disclosed ingredient, purchase basis and remaining evidence questions. A monthly prescription offer, a retailer-priced gel, a liquid bottle and a small acne-treatment tube do not form an equal-duration shopping basket. We have not converted them into one.
The AAD’s acne guidance explains that different acne lesions can need different treatment approaches. If the concern is deep, painful or scarring, a buying list should not delay an appropriate dermatology visit. If the concern is simply appearance, first read what pore-size claims can mean.
A useful shortlist leaves the reader with specific questions to resolve, not a false sense that four unrelated options were tested in one contest. The sponsor’s placement is clear, the alternatives remain identifiable and the missing details stay visible. That is the basis on which this list should be used.